What I am sharing today is [Skin Care Industry Research - Dismantling of Fumei Brands] Report Producer: Solution Consulting.
Featured Reports** Public Title: A global repository of industry reports
With recombinant collagen as the core technology ingredient, and guided by solving skin problems such as sensitivity, dermatitis and acne, and post-care after beauty projects, Kefumei has gradually entered the lives of consumers from a patch of recombinant collagen dressing, extending from medical devices to functional skin care products, and gradually becoming known by more people.
After ten years of precipitation, in 2011, the brand of Fumei was established, and the first second-class medical device product "human-like collagen dressing" was launched, which was applied in the first-class department of public tertiary hospitals across the country.
So far, in the past 12 years, Kefumei's "human-like collagen dressing" is still a best-selling product, and it is actually a "big item" that has passed through the fluctuations of the market cycle.
In recent years, with the upgrading of consumption and the enhancement of consumer awareness, Chinese people have paid more and more attention to skin care issues, and functional skin care products have been valued by people with problem skin and ingredient parties.
The concept of "functional skin care products" became popular in Europe and the United States in 1970, and European cosmeceuticals emphasize functionality compared to mass cosmetics. However, the product design of European cosmeceuticals is not aimed at Asians, and the ingredients and formulations are prone to conflict with Chinese cosmetics regulations.
With differentiated positioning and localized marketing, many domestic skincare products companies that are more suitable for the needs of Chinese consumers have overtaken in recent years.
According to relevant data, the market size of China's functional skin care products will reach 30.8 billion yuan in 2021, an increase of 7.5 billion yuan from 2020 and a year-on-year increase of 3219%, and the scale is expected to reach 211.8 billion yuan in 2027.
Compared with ordinary skin care products, the barriers to functional skin care products are higher, but the user stickiness is also stronger, and consumers have a higher repurchase rate for products with significant effects.
This article is for informational purposes only and does not represent any investment advice from us. To use the information, please refer to the original report. ）
Featured Reports** Public Title: A global repository of industry reports